BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5107268)

  • 21. Studies on the improvement of treatment of habu (Trimeresurus flavoviridis) bites. 7. Experimental studies on the habu venom toxoid by dihydrothioctic acid.
    Sawai Y; Kawamura Y; Fukuyama T; Okonogi T
    Jpn J Exp Med; 1969 Apr; 39(2):109-17. PubMed ID: 4904177
    [No Abstract]   [Full Text] [Related]  

  • 22. [Attenuation of Habu-snake (Trimeresurus flavoviridis) venom treated with alcohol and its effects as an immunizing antigen. 1. Toxicity of the alcohol-treated venom and the immunization test in mice].
    Okonogi T; Hattori Z
    Nihon Saikingaku Zasshi; 1968 Feb; 23(2):137-44. PubMed ID: 5692157
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunogenicity in monkeys of a combined toxoid from the main toxic principles separated from Habu snake venom.
    Kondo H; Sadahiro S; Kondo S; Yamauchi K; Honjo S
    Jpn J Med Sci Biol; 1970 Dec; 23(6):413-8. PubMed ID: 4994228
    [No Abstract]   [Full Text] [Related]  

  • 24. Anticoagulant activity of habu snake (Trimeresurus flavoviridis) venom. II. Effect of crude venom on blood vessels and fibrin clots.
    TATENO I; SUZUKI S; CHIKU N; KITAMOTO O
    Jpn J Exp Med; 1960 Dec; 30():421-6. PubMed ID: 13775455
    [No Abstract]   [Full Text] [Related]  

  • 25. Biochemical studies on the toxoids of venoms of poisonous Indian snakes.
    Baride RM; Jain SD; Gaitonde BB
    Indian J Med Res; 1980 Oct; 72():571-6. PubMed ID: 7228180
    [No Abstract]   [Full Text] [Related]  

  • 26. Toxoid preparation from venom of Bothrops colombiensis (Central and South American snake).
    Rodriquez-Acosta A; Alonso R; Castro I; Aguilar A; Giron ME
    Roum Arch Microbiol Immunol; 1991; 50(3):209-14. PubMed ID: 1821162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biochemical and immunological studies on snake venom. IV. Action of formaldehyde on the alpha toxin of Naja nigricollis venon].
    Dumarey C
    Ann Inst Pasteur (Paris); 1971 Nov; 121(5):675-88. PubMed ID: 5003739
    [No Abstract]   [Full Text] [Related]  

  • 28. The detection of the factor lowering the immunogenicity of toxoid of Clostridium perfringens type A.
    Shemanova GF; Vlasova EV; Sergeeva TI; Panteleyev EI
    Arch Roum Pathol Exp Microbiol; 1981; 40(4):299-303. PubMed ID: 6280638
    [No Abstract]   [Full Text] [Related]  

  • 29. Preparation of toxoids from the venoms of Pakistan species of snakes. (Naja naja, Vipera russellii and Echis carinatus).
    Khan ZH; Lari FA; Ali Z
    Jpn J Med Sci Biol; 1977 Feb; 30(1):19-23. PubMed ID: 875234
    [No Abstract]   [Full Text] [Related]  

  • 30. [Preventive studies on habu snake (Trimeresurus flaviridis) bites with its venom toxoid. 2. Side-effects of the toxoid vaccination in the Ryuku Islands].
    Miyagi F; Hokama Z; Yamakawa M; Miyagi E; Onishi K
    Nihon Saikingaku Zasshi; 1966 Apr; 21(4):206-9. PubMed ID: 6005860
    [No Abstract]   [Full Text] [Related]  

  • 31. A histopathological study on arterial lesions caused by Habu (Trimeresurus flavoviridis) venom.
    Homma M; Kosuge T; Okonogi T; Hattori Z; Sawai Y
    Jpn J Exp Med; 1967 Aug; 37(4):323-36. PubMed ID: 5301402
    [No Abstract]   [Full Text] [Related]  

  • 32. Standardization of habu (Trimeresurus flavoviridis) snake-venom toxoid.
    Sadahiro S; Kondo S; Kondo H; Ohsaka A; Fukushima H; Murata R
    Toxicon; 1978; 16(3):275-82. PubMed ID: 418535
    [No Abstract]   [Full Text] [Related]  

  • 33. Experimental study on cobra venom toxoid.
    Fukuyama T; Sawai Y
    Jpn J Med Sci Biol; 1973 Feb; 26(1):32-3. PubMed ID: 4541842
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative study on the immunogenic properties of Clostridium perfringens type A toxoid.
    Shemanova GF; Vlasova EV; Dmitrieva LN; Trapezov EV; Gorbacheva LD
    J Hyg Epidemiol Microbiol Immunol; 1986; 30(3):323-9. PubMed ID: 2877025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The fate of proteinases of Mamushi venom during preparation of toxoid.
    Tirrell R; Sawai Y; Chinzei H
    Jpn J Exp Med; 1974 Feb; 44(1):13-7. PubMed ID: 4596709
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunization of human beings with Habu toxoid.
    Murata R; Kondo H
    Taiwan Yi Xue Hui Za Zhi; 1972 Jun; 71(6):420. PubMed ID: 4512916
    [No Abstract]   [Full Text] [Related]  

  • 37. [Biochemical studies on Habu (Trimeresurus flavoviridis) with reference to SH radicals].
    Yoshihira A
    Igaku Kenkyu; 1967 Jun; 37(3):263-85. PubMed ID: 5625466
    [No Abstract]   [Full Text] [Related]  

  • 38. THE CHEMICAL MODIFICATION OF NECROGENIC AND PROTEOLYTIC ACTIVITIES OF CROTALIDAE VENOM AND THE USE OF EDTA TO PRODUCE A VENOM TOXOID. REP 599.
    GOUCHER CR; FLOWERS HH
    Rep US Army Med Res Lab; 1963 Dec; ():1-19. PubMed ID: 14131247
    [No Abstract]   [Full Text] [Related]  

  • 39. Action of Trimeresurus flavoviridis venom and the partially purified hemorrhagic principles on animal cells cultivated in vitro.
    Yoshikura H; Ogawa H; Osaka A; Omori-Sato T
    Toxicon; 1966 Nov; 4(3):183-90. PubMed ID: 6005008
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of adjuvants on the immunogenicity of Habu-venom toxoid in the monkey and the guinea pig.
    Sadahiro S; Kondo S; Yamamoto A
    Jpn J Med Sci Biol; 1981 Jun; 34(3):169-73. PubMed ID: 6796732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.